Department of Anesthesiology, University Medical Center Regensburg, 93042 Regensburg, Germany.
Anesth Analg. 2013 Aug;117(2):514-22. doi: 10.1213/ANE.0b013e31829481ed. Epub 2013 Jun 7.
BACKGROUND: Intraarticular injections of local anesthetics are frequently used as part of multimodal pain regimens. However, recent data suggest that local anesthetics affect chondrocyte viability. In this study, we assessed the chondrotoxic effects of mepivacaine, ropivacaine, and bupivacaine. We hypothesized that specific cytotoxic potencies directly correlate with analgesic potencies, and that cytotoxic effects in intact cartilage are different than in osteoarthritic tissue. METHODS: Human articular chondrocytes were exposed to equal and equipotent concentrations of bupivacaine, ropivacaine, and mepivacaine for 1 hour. Cell viability, apoptosis, and necrosis were determined at predefined time points using flow cytometry, live-dead staining, and caspase detection. Intact and osteoarthritic human cartilage explants were treated with equipotent concentrations of named drugs to determine cell viability applying fluorescence microscopy. RESULTS: Chondrotoxic effects increased from ropivacaine to mepivacaine to bupivacaine in a time-dependent and concentration-dependent manner. Compared with control, bupivacaine 0.5% decreased chondrocyte viability to 78% ± 9% (P = 0.0183) 1 hour and 16% ± 10% (P < 0.0001) 24 hours later, as determined by live-dead staining in monolayer cultures. Viability rates were reduced to 80% ± 7% (P = 0.0475) 1 hour and 80% ± 10% (P = 0.0095) 24 hours after treatment with ropivacaine 0.75%. After exposure to mepivacaine 2%, viable cells were scored 36% ± 6% (P < 0.0001) after 1 hour and 30% ± 11% (P < 0.0001) after 24 hours. Ropivacaine treatment was less chondrotoxic than bupivacaine (P = 0.0006) and mepivacaine exposure (P = 0.0059). Exposure to concentrations up to 0.25% of bupivacaine, 0.5% of ropivacaine, and 0.5% of mepivacaine did not reveal significant chondrotoxicity in flow cytometry. However, chondrotoxicity did not correlate with potency of local anesthetics. Immediate cell death was mainly due to necrosis followed by apoptosis. Cellular death rates were clearly higher in osteoarthritic compared with intact cartilage after bupivacaine, mepivacaine, and ropivacaine treatment in a decreasing order. CONCLUSION: Bupivacaine, ropivacaine, and mepivacaine are chondrotoxic in a time-dependent, concentration-dependent, and drug-dependent manner. Chondrotoxic and analgesic potencies do not directly correlate. Cellular death rates were higher in osteoarthritic compared with intact cartilage after local anesthetic treatment.
背景:关节内注射局部麻醉剂常作为多模式疼痛治疗方案的一部分。然而,最近的数据表明局部麻醉剂会影响软骨细胞的活力。在这项研究中,我们评估了甲哌卡因、罗哌卡因和布比卡因的软骨毒性作用。我们假设特定的细胞毒性强度与镇痛强度直接相关,并且完整软骨中的细胞毒性作用与骨关节炎组织中的不同。
方法:将人关节软骨细胞暴露于等浓度和等效浓度的布比卡因、罗哌卡因和甲哌卡因 1 小时。使用流式细胞术、死活染色和半胱天冬酶检测在预设时间点测定细胞活力、细胞凋亡和细胞坏死。用等效浓度的命名药物处理完整和骨关节炎的人软骨外植体,应用荧光显微镜测定细胞活力。
结果:软骨毒性作用呈时间依赖性和浓度依赖性,从罗哌卡因增加到甲哌卡因,再增加到布比卡因。与对照组相比,布比卡因 0.5%在 1 小时后将软骨细胞活力降低至 78%±9%(P=0.0183),24 小时后降低至 16%±10%(P<0.0001),通过单层培养中的死活染色确定。罗哌卡因 0.75%处理 1 小时后,活细胞率降低至 80%±7%(P=0.0475),24 小时后降低至 80%±10%(P=0.0095)。暴露于 2%甲哌卡因后,1 小时后评分存活细胞 36%±6%(P<0.0001),24 小时后评分存活细胞 30%±11%(P<0.0001)。罗哌卡因处理的软骨毒性小于布比卡因(P=0.0006)和甲哌卡因(P=0.0059)。在流式细胞术检测中,浓度高达 0.25%的布比卡因、0.5%的罗哌卡因和 0.5%的甲哌卡因暴露均未显示出明显的软骨毒性。然而,软骨毒性与局部麻醉剂的效力没有直接关系。即刻细胞死亡主要是由于坏死,随后是凋亡。在布比卡因、甲哌卡因和罗哌卡因处理后,骨关节炎软骨中的细胞死亡率明显高于完整软骨,呈降序排列。
结论:布比卡因、罗哌卡因和甲哌卡因以时间依赖性、浓度依赖性和药物依赖性方式具有软骨毒性。软骨毒性和镇痛效力不直接相关。在局部麻醉剂治疗后,骨关节炎软骨中的细胞死亡率明显高于完整软骨。
Arthroscopy. 2013-8-29
J Bone Joint Surg Am. 2008-5
Arthroscopy. 2012-5-11
Knee Surg Sports Traumatol Arthrosc. 2017-3-13
Am J Sports Med. 2008-8
Am J Sports Med. 2012-1-27
Int J Mol Sci. 2024-12-16
Skeletal Radiol. 2025-4
Int J Mol Sci. 2024-6-26
Ther Adv Musculoskelet Dis. 2024-5-23
Osteoarthr Imaging. 2023-9
Arch Orthop Trauma Surg. 2023-10